Published in:
01-06-2011 | Letter to the Editor
Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation
Authors:
James Mahon, Miriam Casey
Published in:
Calcified Tissue International
|
Issue 6/2011
Login to get access
Excerpt
We read with interest in your November issue the article “Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation” by Sridharan et al. While we welcome their input into elucidating the use of FGF-23 as a biomarker in osteoporosis treatment, we would like to address a few issues: the unusual baseline characteristics of the cohort studied and the small number of patients in the study. …